nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2B6—Thiotepa—urinary bladder cancer	0.189	0.381	CbGbCtD
Mexiletine—CYP3A4—Thiotepa—urinary bladder cancer	0.058	0.117	CbGbCtD
Mexiletine—CYP2B6—Cisplatin—urinary bladder cancer	0.0521	0.105	CbGbCtD
Mexiletine—CYP2E1—Etoposide—urinary bladder cancer	0.0519	0.105	CbGbCtD
Mexiletine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0359	0.0726	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0349	0.0705	CbGbCtD
Mexiletine—CYP1A2—Etoposide—urinary bladder cancer	0.03	0.0606	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0169	0.0341	CbGbCtD
Mexiletine—CYP3A4—Etoposide—urinary bladder cancer	0.0157	0.0318	CbGbCtD
Mexiletine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0107	0.0217	CbGbCtD
Mexiletine—CYP1A2—urine—urinary bladder cancer	0.00553	0.0706	CbGeAlD
Mexiletine—SCN9A—prostate gland—urinary bladder cancer	0.00545	0.0696	CbGeAlD
Mexiletine—AHR—prostate gland—urinary bladder cancer	0.00532	0.0679	CbGeAlD
Mexiletine—CYP2E1—urine—urinary bladder cancer	0.00498	0.0635	CbGeAlD
Mexiletine—SCN4A—prostate gland—urinary bladder cancer	0.00486	0.0621	CbGeAlD
Mexiletine—AHR—seminal vesicle—urinary bladder cancer	0.0045	0.0574	CbGeAlD
Mexiletine—CYP3A4—urine—urinary bladder cancer	0.004	0.0511	CbGeAlD
Mexiletine—CYP2D6—urine—urinary bladder cancer	0.00394	0.0503	CbGeAlD
Mexiletine—AHR—smooth muscle tissue—urinary bladder cancer	0.00377	0.0481	CbGeAlD
Mexiletine—AHR—urethra—urinary bladder cancer	0.00356	0.0455	CbGeAlD
Mexiletine—SCN4A—renal system—urinary bladder cancer	0.00331	0.0423	CbGeAlD
Mexiletine—AHR—female reproductive system—urinary bladder cancer	0.0029	0.0371	CbGeAlD
Mexiletine—AHR—vagina—urinary bladder cancer	0.00263	0.0335	CbGeAlD
Mexiletine—SCN2A—vagina—urinary bladder cancer	0.00212	0.0271	CbGeAlD
Mexiletine—SCN5A—vagina—urinary bladder cancer	0.00186	0.0238	CbGeAlD
Mexiletine—CYP2E1—prostate gland—urinary bladder cancer	0.00179	0.0228	CbGeAlD
Mexiletine—SCN9A—lymph node—urinary bladder cancer	0.00174	0.0222	CbGeAlD
Mexiletine—AHR—lymph node—urinary bladder cancer	0.0017	0.0217	CbGeAlD
Mexiletine—CYP2E1—seminal vesicle—urinary bladder cancer	0.00151	0.0193	CbGeAlD
Mexiletine—CYP1A2—renal system—urinary bladder cancer	0.00135	0.0173	CbGeAlD
Mexiletine—SCN10A—lymph node—urinary bladder cancer	0.00133	0.0169	CbGeAlD
Mexiletine—CYP2B6—renal system—urinary bladder cancer	0.0013	0.0166	CbGeAlD
Mexiletine—CYP2E1—renal system—urinary bladder cancer	0.00122	0.0155	CbGeAlD
Mexiletine—CYP2E1—urethra—urinary bladder cancer	0.0012	0.0153	CbGeAlD
Mexiletine—CYP2B6—female reproductive system—urinary bladder cancer	0.00104	0.0133	CbGeAlD
Mexiletine—CYP3A4—renal system—urinary bladder cancer	0.00098	0.0125	CbGeAlD
Mexiletine—CYP2E1—female reproductive system—urinary bladder cancer	0.000975	0.0124	CbGeAlD
Mexiletine—CYP2D6—renal system—urinary bladder cancer	0.000964	0.0123	CbGeAlD
Mexiletine—CYP2B6—vagina—urinary bladder cancer	0.00094	0.012	CbGeAlD
Mexiletine—CYP3A4—female reproductive system—urinary bladder cancer	0.000784	0.01	CbGeAlD
Mexiletine—CYP2D6—female reproductive system—urinary bladder cancer	0.000772	0.00986	CbGeAlD
Mexiletine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000407	0.00149	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000406	0.00148	CcSEcCtD
Mexiletine—Dry skin—Epirubicin—urinary bladder cancer	0.000405	0.00148	CcSEcCtD
Mexiletine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000404	0.00148	CcSEcCtD
Mexiletine—Chest pain—Etoposide—urinary bladder cancer	0.000404	0.00148	CcSEcCtD
Mexiletine—Somnolence—Gemcitabine—urinary bladder cancer	0.000403	0.00147	CcSEcCtD
Mexiletine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.0004	0.00146	CcSEcCtD
Mexiletine—Pancreatitis—Methotrexate—urinary bladder cancer	0.0004	0.00146	CcSEcCtD
Mexiletine—Discomfort—Etoposide—urinary bladder cancer	0.000399	0.00146	CcSEcCtD
Mexiletine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000397	0.00145	CcSEcCtD
Mexiletine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000397	0.00145	CcSEcCtD
Mexiletine—Somnolence—Fluorouracil—urinary bladder cancer	0.000396	0.00145	CcSEcCtD
Mexiletine—Hypotension—Cisplatin—urinary bladder cancer	0.000395	0.00144	CcSEcCtD
Mexiletine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000392	0.00143	CcSEcCtD
Mexiletine—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000391	0.00143	CcSEcCtD
Mexiletine—Fatigue—Gemcitabine—urinary bladder cancer	0.000391	0.00143	CcSEcCtD
Mexiletine—Confusional state—Etoposide—urinary bladder cancer	0.00039	0.00143	CcSEcCtD
Mexiletine—Pain—Gemcitabine—urinary bladder cancer	0.000388	0.00142	CcSEcCtD
Mexiletine—Constipation—Gemcitabine—urinary bladder cancer	0.000388	0.00142	CcSEcCtD
Mexiletine—Asthenia—Thiotepa—urinary bladder cancer	0.000387	0.00141	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000385	0.00141	CcSEcCtD
Mexiletine—Ataxia—Doxorubicin—urinary bladder cancer	0.000384	0.0014	CcSEcCtD
Mexiletine—Dysphagia—Epirubicin—urinary bladder cancer	0.000382	0.00139	CcSEcCtD
Mexiletine—Neutropenia—Methotrexate—urinary bladder cancer	0.000381	0.00139	CcSEcCtD
Mexiletine—Pain—Fluorouracil—urinary bladder cancer	0.000381	0.00139	CcSEcCtD
Mexiletine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000379	0.00139	CcSEcCtD
Mexiletine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000379	0.00138	CcSEcCtD
Mexiletine—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000377	0.00138	CcSEcCtD
Mexiletine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000377	0.00138	CcSEcCtD
Mexiletine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000376	0.00137	CcSEcCtD
Mexiletine—Dry skin—Doxorubicin—urinary bladder cancer	0.000374	0.00137	CcSEcCtD
Mexiletine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000374	0.00137	CcSEcCtD
Mexiletine—Pancreatitis—Epirubicin—urinary bladder cancer	0.000374	0.00137	CcSEcCtD
Mexiletine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000374	0.00137	CcSEcCtD
Mexiletine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000372	0.00136	CcSEcCtD
Mexiletine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000369	0.00135	CcSEcCtD
Mexiletine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000367	0.00134	CcSEcCtD
Mexiletine—Drowsiness—Methotrexate—urinary bladder cancer	0.000364	0.00133	CcSEcCtD
Mexiletine—Depression—Methotrexate—urinary bladder cancer	0.000363	0.00132	CcSEcCtD
Mexiletine—Hypotension—Etoposide—urinary bladder cancer	0.000362	0.00132	CcSEcCtD
Mexiletine—Pain—Cisplatin—urinary bladder cancer	0.000361	0.00132	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00036	0.00132	CcSEcCtD
Mexiletine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000358	0.00131	CcSEcCtD
Mexiletine—Neutropenia—Epirubicin—urinary bladder cancer	0.000357	0.0013	CcSEcCtD
Mexiletine—Dizziness—Thiotepa—urinary bladder cancer	0.000356	0.0013	CcSEcCtD
Mexiletine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000353	0.00129	CcSEcCtD
Mexiletine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000352	0.00129	CcSEcCtD
Mexiletine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000348	0.00127	CcSEcCtD
Mexiletine—Paraesthesia—Etoposide—urinary bladder cancer	0.000348	0.00127	CcSEcCtD
Mexiletine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000346	0.00126	CcSEcCtD
Mexiletine—Dyspnoea—Etoposide—urinary bladder cancer	0.000345	0.00126	CcSEcCtD
Mexiletine—Somnolence—Etoposide—urinary bladder cancer	0.000344	0.00126	CcSEcCtD
Mexiletine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000344	0.00126	CcSEcCtD
Mexiletine—Vomiting—Thiotepa—urinary bladder cancer	0.000343	0.00125	CcSEcCtD
Mexiletine—Drowsiness—Epirubicin—urinary bladder cancer	0.00034	0.00124	CcSEcCtD
Mexiletine—Rash—Thiotepa—urinary bladder cancer	0.00034	0.00124	CcSEcCtD
Mexiletine—Dermatitis—Thiotepa—urinary bladder cancer	0.000339	0.00124	CcSEcCtD
Mexiletine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000339	0.00124	CcSEcCtD
Mexiletine—Headache—Thiotepa—urinary bladder cancer	0.000338	0.00123	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000337	0.00123	CcSEcCtD
Mexiletine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000334	0.00122	CcSEcCtD
Mexiletine—Fatigue—Etoposide—urinary bladder cancer	0.000334	0.00122	CcSEcCtD
Mexiletine—Constipation—Etoposide—urinary bladder cancer	0.000331	0.00121	CcSEcCtD
Mexiletine—Pain—Etoposide—urinary bladder cancer	0.000331	0.00121	CcSEcCtD
Mexiletine—Neutropenia—Doxorubicin—urinary bladder cancer	0.00033	0.00121	CcSEcCtD
Mexiletine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000328	0.0012	CcSEcCtD
Mexiletine—Hepatitis—Methotrexate—urinary bladder cancer	0.000326	0.00119	CcSEcCtD
Mexiletine—Asthenia—Gemcitabine—urinary bladder cancer	0.000325	0.00119	CcSEcCtD
Mexiletine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000324	0.00118	CcSEcCtD
Mexiletine—Nausea—Thiotepa—urinary bladder cancer	0.00032	0.00117	CcSEcCtD
Mexiletine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000319	0.00117	CcSEcCtD
Mexiletine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000318	0.00116	CcSEcCtD
Mexiletine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000317	0.00116	CcSEcCtD
Mexiletine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000315	0.00115	CcSEcCtD
Mexiletine—Visual impairment—Methotrexate—urinary bladder cancer	0.000315	0.00115	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000312	0.00114	CcSEcCtD
Mexiletine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000311	0.00114	CcSEcCtD
Mexiletine—Bradycardia—Epirubicin—urinary bladder cancer	0.000311	0.00114	CcSEcCtD
Mexiletine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00031	0.00113	CcSEcCtD
Mexiletine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000309	0.00113	CcSEcCtD
Mexiletine—Abdominal pain—Etoposide—urinary bladder cancer	0.000306	0.00112	CcSEcCtD
Mexiletine—Body temperature increased—Etoposide—urinary bladder cancer	0.000306	0.00112	CcSEcCtD
Mexiletine—Hepatitis—Epirubicin—urinary bladder cancer	0.000305	0.00112	CcSEcCtD
Mexiletine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000305	0.00111	CcSEcCtD
Mexiletine—Tinnitus—Methotrexate—urinary bladder cancer	0.000304	0.00111	CcSEcCtD
Mexiletine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000304	0.00111	CcSEcCtD
Mexiletine—Asthenia—Cisplatin—urinary bladder cancer	0.000303	0.00111	CcSEcCtD
Mexiletine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000303	0.00111	CcSEcCtD
Mexiletine—Dizziness—Fluorouracil—urinary bladder cancer	0.000295	0.00108	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—urinary bladder cancer	0.000294	0.00108	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000294	0.00107	CcSEcCtD
Mexiletine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000289	0.00106	CcSEcCtD
Mexiletine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000289	0.00106	CcSEcCtD
Mexiletine—Alopecia—Methotrexate—urinary bladder cancer	0.000288	0.00105	CcSEcCtD
Mexiletine—Vomiting—Gemcitabine—urinary bladder cancer	0.000288	0.00105	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000288	0.00105	CcSEcCtD
Mexiletine—Rash—Gemcitabine—urinary bladder cancer	0.000286	0.00104	CcSEcCtD
Mexiletine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000286	0.00104	CcSEcCtD
Mexiletine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000285	0.00104	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—urinary bladder cancer	0.000285	0.00104	CcSEcCtD
Mexiletine—Headache—Gemcitabine—urinary bladder cancer	0.000284	0.00104	CcSEcCtD
Mexiletine—Vomiting—Fluorouracil—urinary bladder cancer	0.000283	0.00104	CcSEcCtD
Mexiletine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000283	0.00103	CcSEcCtD
Mexiletine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000281	0.00103	CcSEcCtD
Mexiletine—Rash—Fluorouracil—urinary bladder cancer	0.000281	0.00103	CcSEcCtD
Mexiletine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000281	0.00103	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00028	0.00102	CcSEcCtD
Mexiletine—Headache—Fluorouracil—urinary bladder cancer	0.000279	0.00102	CcSEcCtD
Mexiletine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000278	0.00102	CcSEcCtD
Mexiletine—Asthenia—Etoposide—urinary bladder cancer	0.000278	0.00101	CcSEcCtD
Mexiletine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000273	0.000997	CcSEcCtD
Mexiletine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000272	0.000995	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—urinary bladder cancer	0.00027	0.000986	CcSEcCtD
Mexiletine—Nausea—Gemcitabine—urinary bladder cancer	0.000269	0.000984	CcSEcCtD
Mexiletine—Vomiting—Cisplatin—urinary bladder cancer	0.000269	0.000982	CcSEcCtD
Mexiletine—Vision blurred—Methotrexate—urinary bladder cancer	0.000268	0.000978	CcSEcCtD
Mexiletine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000267	0.000976	CcSEcCtD
Mexiletine—Rash—Cisplatin—urinary bladder cancer	0.000266	0.000974	CcSEcCtD
Mexiletine—Dermatitis—Cisplatin—urinary bladder cancer	0.000266	0.000973	CcSEcCtD
Mexiletine—Diarrhoea—Etoposide—urinary bladder cancer	0.000265	0.000968	CcSEcCtD
Mexiletine—Nausea—Fluorouracil—urinary bladder cancer	0.000265	0.000967	CcSEcCtD
Mexiletine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000264	0.000963	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000264	0.000963	CcSEcCtD
Mexiletine—Tension—Epirubicin—urinary bladder cancer	0.000261	0.000953	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—urinary bladder cancer	0.00026	0.000951	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—urinary bladder cancer	0.000258	0.000944	CcSEcCtD
Mexiletine—Malaise—Methotrexate—urinary bladder cancer	0.000256	0.000936	CcSEcCtD
Mexiletine—Dizziness—Etoposide—urinary bladder cancer	0.000256	0.000935	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000256	0.000934	CcSEcCtD
Mexiletine—Leukopenia—Methotrexate—urinary bladder cancer	0.000254	0.000929	CcSEcCtD
Mexiletine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000252	0.000923	CcSEcCtD
Mexiletine—Nausea—Cisplatin—urinary bladder cancer	0.000251	0.000917	CcSEcCtD
Mexiletine—Vision blurred—Epirubicin—urinary bladder cancer	0.000251	0.000916	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—urinary bladder cancer	0.00025	0.000913	CcSEcCtD
Mexiletine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000247	0.000901	CcSEcCtD
Mexiletine—Convulsion—Methotrexate—urinary bladder cancer	0.000246	0.000899	CcSEcCtD
Mexiletine—Vomiting—Etoposide—urinary bladder cancer	0.000246	0.000899	CcSEcCtD
Mexiletine—Rash—Etoposide—urinary bladder cancer	0.000244	0.000892	CcSEcCtD
Mexiletine—Dermatitis—Etoposide—urinary bladder cancer	0.000244	0.000891	CcSEcCtD
Mexiletine—Headache—Etoposide—urinary bladder cancer	0.000243	0.000886	CcSEcCtD
Mexiletine—Arthralgia—Methotrexate—urinary bladder cancer	0.000242	0.000884	CcSEcCtD
Mexiletine—Chest pain—Methotrexate—urinary bladder cancer	0.000242	0.000884	CcSEcCtD
Mexiletine—Tension—Doxorubicin—urinary bladder cancer	0.000241	0.000882	CcSEcCtD
Mexiletine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000241	0.00088	CcSEcCtD
Mexiletine—Malaise—Epirubicin—urinary bladder cancer	0.00024	0.000876	CcSEcCtD
Mexiletine—Discomfort—Methotrexate—urinary bladder cancer	0.000239	0.000873	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—urinary bladder cancer	0.000239	0.000873	CcSEcCtD
Mexiletine—Syncope—Epirubicin—urinary bladder cancer	0.000238	0.000871	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—urinary bladder cancer	0.000238	0.00087	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000237	0.000864	CcSEcCtD
Mexiletine—Palpitations—Epirubicin—urinary bladder cancer	0.000235	0.000859	CcSEcCtD
Mexiletine—Confusional state—Methotrexate—urinary bladder cancer	0.000234	0.000854	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000234	0.000854	CcSEcCtD
Mexiletine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000232	0.000847	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—urinary bladder cancer	0.00023	0.000842	CcSEcCtD
Mexiletine—Nausea—Etoposide—urinary bladder cancer	0.00023	0.00084	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—urinary bladder cancer	0.00023	0.000839	CcSEcCtD
Mexiletine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000228	0.000834	CcSEcCtD
Mexiletine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000227	0.00083	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—urinary bladder cancer	0.000226	0.000827	CcSEcCtD
Mexiletine—Chest pain—Epirubicin—urinary bladder cancer	0.000226	0.000827	CcSEcCtD
Mexiletine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000224	0.000819	CcSEcCtD
Mexiletine—Discomfort—Epirubicin—urinary bladder cancer	0.000224	0.000817	CcSEcCtD
Mexiletine—Malaise—Doxorubicin—urinary bladder cancer	0.000222	0.000811	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—urinary bladder cancer	0.000221	0.000809	CcSEcCtD
Mexiletine—Syncope—Doxorubicin—urinary bladder cancer	0.000221	0.000806	CcSEcCtD
Mexiletine—Leukopenia—Doxorubicin—urinary bladder cancer	0.00022	0.000805	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—urinary bladder cancer	0.000219	0.0008	CcSEcCtD
Mexiletine—Palpitations—Doxorubicin—urinary bladder cancer	0.000217	0.000794	CcSEcCtD
Mexiletine—Oedema—Epirubicin—urinary bladder cancer	0.000217	0.000793	CcSEcCtD
Mexiletine—Hypotension—Methotrexate—urinary bladder cancer	0.000217	0.000792	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000216	0.00079	CcSEcCtD
Mexiletine—Shock—Epirubicin—urinary bladder cancer	0.000213	0.00078	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—urinary bladder cancer	0.000213	0.000779	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000212	0.000776	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—urinary bladder cancer	0.000212	0.000776	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000211	0.000772	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00021	0.000767	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000209	0.000765	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—urinary bladder cancer	0.000209	0.000765	CcSEcCtD
Mexiletine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000208	0.000761	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—urinary bladder cancer	0.000207	0.000756	CcSEcCtD
Mexiletine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000207	0.000755	CcSEcCtD
Mexiletine—Somnolence—Methotrexate—urinary bladder cancer	0.000206	0.000753	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000205	0.000748	CcSEcCtD
Mexiletine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000204	0.000746	CcSEcCtD
Mexiletine—Hypotension—Epirubicin—urinary bladder cancer	0.000203	0.000741	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—urinary bladder cancer	0.000202	0.00074	CcSEcCtD
Mexiletine—Oedema—Doxorubicin—urinary bladder cancer	0.000201	0.000734	CcSEcCtD
Mexiletine—Fatigue—Methotrexate—urinary bladder cancer	0.0002	0.00073	CcSEcCtD
Mexiletine—Pain—Methotrexate—urinary bladder cancer	0.000198	0.000725	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000198	0.000722	CcSEcCtD
Mexiletine—Shock—Doxorubicin—urinary bladder cancer	0.000198	0.000722	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000197	0.000718	CcSEcCtD
Mexiletine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000195	0.000712	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000194	0.000709	CcSEcCtD
Mexiletine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000193	0.000707	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—urinary bladder cancer	0.000193	0.000705	CcSEcCtD
Mexiletine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000191	0.000698	CcSEcCtD
Mexiletine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000191	0.000698	CcSEcCtD
Mexiletine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00019	0.000693	CcSEcCtD
Mexiletine—Hypotension—Doxorubicin—urinary bladder cancer	0.000188	0.000686	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—urinary bladder cancer	0.000187	0.000684	CcSEcCtD
Mexiletine—Pain—Epirubicin—urinary bladder cancer	0.000186	0.000678	CcSEcCtD
Mexiletine—Constipation—Epirubicin—urinary bladder cancer	0.000186	0.000678	CcSEcCtD
Mexiletine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000183	0.00067	CcSEcCtD
Mexiletine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000183	0.00067	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000183	0.000668	CcSEcCtD
Mexiletine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00018	0.000659	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000179	0.000654	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000179	0.000653	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—urinary bladder cancer	0.000179	0.000652	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000177	0.000648	CcSEcCtD
Mexiletine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000177	0.000646	CcSEcCtD
Mexiletine—Fatigue—Doxorubicin—urinary bladder cancer	0.000173	0.000633	CcSEcCtD
Mexiletine—Pain—Doxorubicin—urinary bladder cancer	0.000172	0.000627	CcSEcCtD
Mexiletine—Constipation—Doxorubicin—urinary bladder cancer	0.000172	0.000627	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000172	0.000627	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000172	0.000627	CcSEcCtD
Mexiletine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000171	0.000624	CcSEcCtD
Mexiletine—Asthenia—Methotrexate—urinary bladder cancer	0.000166	0.000608	CcSEcCtD
Mexiletine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000165	0.000605	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000164	0.0006	CcSEcCtD
Mexiletine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00016	0.000584	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000159	0.00058	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000159	0.00058	CcSEcCtD
Mexiletine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000159	0.00058	CcSEcCtD
Mexiletine—Asthenia—Epirubicin—urinary bladder cancer	0.000156	0.000569	CcSEcCtD
Mexiletine—Dizziness—Methotrexate—urinary bladder cancer	0.000153	0.00056	CcSEcCtD
Mexiletine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000148	0.000543	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000148	0.000541	CcSEcCtD
Mexiletine—Vomiting—Methotrexate—urinary bladder cancer	0.000147	0.000539	CcSEcCtD
Mexiletine—Rash—Methotrexate—urinary bladder cancer	0.000146	0.000534	CcSEcCtD
Mexiletine—Dermatitis—Methotrexate—urinary bladder cancer	0.000146	0.000534	CcSEcCtD
Mexiletine—Headache—Methotrexate—urinary bladder cancer	0.000145	0.000531	CcSEcCtD
Mexiletine—Asthenia—Doxorubicin—urinary bladder cancer	0.000144	0.000526	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—urinary bladder cancer	0.000144	0.000524	CcSEcCtD
Mexiletine—Vomiting—Epirubicin—urinary bladder cancer	0.000138	0.000504	CcSEcCtD
Mexiletine—Nausea—Methotrexate—urinary bladder cancer	0.000138	0.000503	CcSEcCtD
Mexiletine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000137	0.000502	CcSEcCtD
Mexiletine—Rash—Epirubicin—urinary bladder cancer	0.000137	0.0005	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—urinary bladder cancer	0.000137	0.000499	CcSEcCtD
Mexiletine—Headache—Epirubicin—urinary bladder cancer	0.000136	0.000497	CcSEcCtD
Mexiletine—Dizziness—Doxorubicin—urinary bladder cancer	0.000133	0.000485	CcSEcCtD
Mexiletine—Nausea—Epirubicin—urinary bladder cancer	0.000129	0.000471	CcSEcCtD
Mexiletine—Vomiting—Doxorubicin—urinary bladder cancer	0.000128	0.000466	CcSEcCtD
Mexiletine—Rash—Doxorubicin—urinary bladder cancer	0.000127	0.000463	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000126	0.000462	CcSEcCtD
Mexiletine—Headache—Doxorubicin—urinary bladder cancer	0.000126	0.00046	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—PPARG—urinary bladder cancer	0.000124	0.000813	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CREBBP—urinary bladder cancer	0.000124	0.00081	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CREBBP—urinary bladder cancer	0.000124	0.00081	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000123	0.000803	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—NCOR1—urinary bladder cancer	0.000122	0.000797	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—RHOA—urinary bladder cancer	0.000122	0.000797	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000121	0.000792	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000121	0.000792	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—MMP9—urinary bladder cancer	0.00012	0.000786	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CREBBP—urinary bladder cancer	0.00012	0.000781	CbGpPWpGaD
Mexiletine—Nausea—Doxorubicin—urinary bladder cancer	0.000119	0.000436	CcSEcCtD
Mexiletine—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000118	0.000768	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000117	0.000764	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000117	0.000763	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000115	0.000754	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—SRC—urinary bladder cancer	0.000115	0.000751	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—SRC—urinary bladder cancer	0.000115	0.000751	CbGpPWpGaD
Mexiletine—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000113	0.000741	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—ERBB2—urinary bladder cancer	0.000113	0.000738	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000112	0.000734	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—RHOA—urinary bladder cancer	0.000112	0.000732	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—RHOA—urinary bladder cancer	0.000112	0.000732	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—SRC—urinary bladder cancer	0.000111	0.000725	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—EGFR—urinary bladder cancer	0.00011	0.000717	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—RHOA—urinary bladder cancer	0.000108	0.000706	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—RHOA—urinary bladder cancer	0.000107	0.000696	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000106	0.000692	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—ERBB2—urinary bladder cancer	0.000104	0.000678	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—ERBB2—urinary bladder cancer	0.000104	0.000678	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—KRAS—urinary bladder cancer	0.000104	0.000677	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000101	0.000659	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000101	0.000659	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—EGFR—urinary bladder cancer	0.000101	0.000659	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—EGFR—urinary bladder cancer	0.000101	0.000659	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—ERBB2—urinary bladder cancer	0.0001	0.000654	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—ERBB2—urinary bladder cancer	9.86e-05	0.000644	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	9.81e-05	0.000641	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	9.81e-05	0.000641	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—EGFR—urinary bladder cancer	9.73e-05	0.000635	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MMP9—urinary bladder cancer	9.69e-05	0.000633	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CDK4—urinary bladder cancer	9.63e-05	0.000629	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	9.62e-05	0.000628	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—KRAS—urinary bladder cancer	9.53e-05	0.000622	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—KRAS—urinary bladder cancer	9.53e-05	0.000622	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.49e-05	0.00062	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.36e-05	0.000611	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—EP300—urinary bladder cancer	9.19e-05	0.0006	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—KRAS—urinary bladder cancer	9.19e-05	0.0006	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	9.08e-05	0.000593	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—SRC—urinary bladder cancer	8.94e-05	0.000583	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MMP9—urinary bladder cancer	8.91e-05	0.000582	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MMP9—urinary bladder cancer	8.91e-05	0.000582	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	8.84e-05	0.000577	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—HRAS—urinary bladder cancer	8.81e-05	0.000575	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	8.79e-05	0.000574	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.75e-05	0.000572	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—PPARG—urinary bladder cancer	8.75e-05	0.000571	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.72e-05	0.000569	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	8.6e-05	0.000561	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	8.6e-05	0.000561	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MMP9—urinary bladder cancer	8.59e-05	0.000561	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	8.48e-05	0.000554	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MMP9—urinary bladder cancer	8.46e-05	0.000552	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EP300—urinary bladder cancer	8.44e-05	0.000551	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—EP300—urinary bladder cancer	8.44e-05	0.000551	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CREBBP—urinary bladder cancer	8.41e-05	0.000549	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	8.31e-05	0.000542	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—SRC—urinary bladder cancer	8.21e-05	0.000536	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—SRC—urinary bladder cancer	8.21e-05	0.000536	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	8.19e-05	0.000535	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	8.19e-05	0.000535	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	8.15e-05	0.000532	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—EP300—urinary bladder cancer	8.14e-05	0.000532	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	8.12e-05	0.00053	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—HRAS—urinary bladder cancer	8.1e-05	0.000529	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—HRAS—urinary bladder cancer	8.1e-05	0.000529	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	8.04e-05	0.000525	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NAT1—urinary bladder cancer	8.04e-05	0.000525	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.04e-05	0.000525	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—SRC—urinary bladder cancer	7.92e-05	0.000517	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	7.87e-05	0.000514	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NAT1—urinary bladder cancer	7.87e-05	0.000514	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—EGFR—urinary bladder cancer	7.83e-05	0.000511	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—HRAS—urinary bladder cancer	7.81e-05	0.00051	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—SRC—urinary bladder cancer	7.8e-05	0.000509	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—RHOA—urinary bladder cancer	7.6e-05	0.000497	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	7.49e-05	0.000489	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TNF—urinary bladder cancer	7.46e-05	0.000487	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—KRAS—urinary bladder cancer	7.4e-05	0.000483	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.39e-05	0.000482	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	7.35e-05	0.00048	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	7.2e-05	0.00047	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EGFR—urinary bladder cancer	7.2e-05	0.00047	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—EGFR—urinary bladder cancer	7.2e-05	0.00047	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—ERBB2—urinary bladder cancer	7.04e-05	0.00046	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—EGFR—urinary bladder cancer	6.94e-05	0.000453	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	6.9e-05	0.000451	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TNF—urinary bladder cancer	6.85e-05	0.000448	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TNF—urinary bladder cancer	6.85e-05	0.000448	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—EGFR—urinary bladder cancer	6.84e-05	0.000446	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—KRAS—urinary bladder cancer	6.8e-05	0.000444	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—KRAS—urinary bladder cancer	6.8e-05	0.000444	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	6.62e-05	0.000432	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TNF—urinary bladder cancer	6.61e-05	0.000432	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—KRAS—urinary bladder cancer	6.56e-05	0.000428	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	6.48e-05	0.000423	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—KRAS—urinary bladder cancer	6.46e-05	0.000422	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.29e-05	0.000411	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HRAS—urinary bladder cancer	6.29e-05	0.000411	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	6.25e-05	0.000408	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.2e-05	0.000405	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	6.12e-05	0.0004	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	6.09e-05	0.000398	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	6.04e-05	0.000394	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	5.97e-05	0.00039	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	5.89e-05	0.000385	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.78e-05	0.000378	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HRAS—urinary bladder cancer	5.78e-05	0.000377	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HRAS—urinary bladder cancer	5.78e-05	0.000377	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—EP300—urinary bladder cancer	5.72e-05	0.000374	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.7e-05	0.000372	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	5.59e-05	0.000365	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	5.59e-05	0.000365	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HRAS—urinary bladder cancer	5.57e-05	0.000364	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—SRC—urinary bladder cancer	5.57e-05	0.000363	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—HRAS—urinary bladder cancer	5.49e-05	0.000359	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	5.11e-05	0.000334	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.99e-05	0.000326	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	4.88e-05	0.000319	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TYMP—urinary bladder cancer	4.87e-05	0.000318	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	4.77e-05	0.000312	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.73e-05	0.000309	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.73e-05	0.000309	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.66e-05	0.000304	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TNF—urinary bladder cancer	4.65e-05	0.000303	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	4.61e-05	0.000301	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	4.6e-05	0.0003	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NAT2—urinary bladder cancer	4.41e-05	0.000288	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.35e-05	0.000284	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.33e-05	0.000283	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	4.31e-05	0.000282	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	4.24e-05	0.000277	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	3.92e-05	0.000256	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.9e-05	0.000255	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.85e-05	0.000252	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.8e-05	0.000248	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	3.72e-05	0.000243	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.68e-05	0.00024	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.65e-05	0.000239	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.65e-05	0.000239	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.59e-05	0.000234	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	3.52e-05	0.00023	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	3.52e-05	0.00023	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	3.45e-05	0.000225	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	3.45e-05	0.000225	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	3.42e-05	0.000223	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.39e-05	0.000221	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	3.35e-05	0.000218	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.34e-05	0.000218	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.06e-05	0.0002	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.01e-05	0.000196	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.88e-05	0.000188	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.87e-05	0.000187	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.84e-05	0.000186	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.84e-05	0.000185	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	2.78e-05	0.000182	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.77e-05	0.000181	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.75e-05	0.00018	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.64e-05	0.000173	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.59e-05	0.000169	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.45e-05	0.00016	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.45e-05	0.00016	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.37e-05	0.000155	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	2.37e-05	0.000155	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	2.32e-05	0.000151	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.24e-05	0.000146	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.21e-05	0.000145	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	2.2e-05	0.000144	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.18e-05	0.000142	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.18e-05	0.000142	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.16e-05	0.000141	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.13e-05	0.000139	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.13e-05	0.000139	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	2.08e-05	0.000136	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.07e-05	0.000135	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.07e-05	0.000135	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.06e-05	0.000135	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	2.05e-05	0.000134	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.04e-05	0.000133	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.01e-05	0.000131	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2e-05	0.000131	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2e-05	0.000131	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.98e-05	0.000129	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.97e-05	0.000129	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.92e-05	0.000126	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.88e-05	0.000123	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.73e-05	0.000113	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.67e-05	0.000109	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.65e-05	0.000107	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.62e-05	0.000106	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.6e-05	0.000105	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.6e-05	0.000105	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.56e-05	0.000102	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.55e-05	0.000101	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.53e-05	9.99e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.53e-05	9.97e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.51e-05	9.87e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.51e-05	9.87e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.5e-05	9.78e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.47e-05	9.58e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.45e-05	9.46e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.42e-05	9.28e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.41e-05	9.24e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.39e-05	9.1e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.35e-05	8.81e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.34e-05	8.73e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.3e-05	8.46e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.29e-05	8.42e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.28e-05	8.37e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.28e-05	8.37e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.23e-05	8.01e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.23e-05	8.01e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.2e-05	7.87e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.2e-05	7.84e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.13e-05	7.39e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.08e-05	7.08e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.08e-05	7.03e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.07e-05	6.99e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.05e-05	6.84e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.04e-05	6.8e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.02e-05	6.66e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1e-05	6.53e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—EP300—urinary bladder cancer	9.99e-06	6.52e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.89e-06	6.46e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.89e-06	6.46e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.47e-06	6.18e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.3e-06	6.07e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	9.18e-06	6e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	8.82e-06	5.76e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.74e-06	5.71e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	8.53e-06	5.57e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	7.43e-06	4.85e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	7.22e-06	4.72e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—EP300—urinary bladder cancer	7.09e-06	4.63e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.09e-06	4.63e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.81e-06	4.44e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	6.3e-06	4.11e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—EP300—urinary bladder cancer	6.01e-06	3.92e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.57e-06	3.64e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.86e-06	3.17e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.64e-06	3.03e-05	CbGpPWpGaD
